FI834634A0 - Vasotocin-derivat - Google Patents

Vasotocin-derivat

Info

Publication number
FI834634A0
FI834634A0 FI834634A FI834634A FI834634A0 FI 834634 A0 FI834634 A0 FI 834634A0 FI 834634 A FI834634 A FI 834634A FI 834634 A FI834634 A FI 834634A FI 834634 A0 FI834634 A0 FI 834634A0
Authority
FI
Finland
Prior art keywords
peptide residue
sub
derivatives
vasotocin
residue
Prior art date
Application number
FI834634A
Other languages
English (en)
Other versions
FI834634A (fi
FI78305C (fi
FI78305B (fi
Inventor
Per Olof Ragnar Melin
Jerzy Andrzej Trojnar
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8207277A external-priority patent/SE8207277L/xx
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of FI834634A0 publication Critical patent/FI834634A0/fi
Publication of FI834634A publication Critical patent/FI834634A/fi
Application granted granted Critical
Publication of FI78305B publication Critical patent/FI78305B/fi
Publication of FI78305C publication Critical patent/FI78305C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI834634A 1982-12-21 1983-12-16 Foerfarande foer framstaellning av vasotocin-derivat. FI78305C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8207277A SE8207277L (sv) 1982-12-21 1982-12-21 Vasotocin-derivat
SE8207277 1982-12-21
SE8302505 1983-05-03
SE8302505A SE8302505L (sv) 1982-12-21 1983-05-03 Vasotocin-derivat

Publications (4)

Publication Number Publication Date
FI834634A0 true FI834634A0 (fi) 1983-12-16
FI834634A FI834634A (fi) 1984-06-22
FI78305B FI78305B (fi) 1989-03-31
FI78305C FI78305C (fi) 1989-07-10

Family

ID=26658329

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834634A FI78305C (fi) 1982-12-21 1983-12-16 Foerfarande foer framstaellning av vasotocin-derivat.

Country Status (12)

Country Link
US (1) US4504469A (fi)
EP (1) EP0112809B1 (fi)
AT (1) ATE20072T1 (fi)
AU (1) AU564255B2 (fi)
CA (1) CA1216843A (fi)
DE (2) DE3363830D1 (fi)
DK (1) DK163186C (fi)
ES (1) ES8607990A1 (fi)
FI (1) FI78305C (fi)
IL (1) IL70498A (fi)
NL (1) NL300012I2 (fi)
NO (1) NO160144C (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599324A (en) * 1984-11-21 1986-07-08 Smithkline Beckman Corporation V1-vasopressin antagonists
US4711877A (en) * 1985-09-18 1987-12-08 Smithkline Beckman Corporation 6-pen-vasopressin compounds
FR2597483B1 (fr) * 1986-04-18 1993-09-10 Flork Michel Nouveaux peptides diuretiques et natriuretiques.
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
AT398766B (de) * 1988-05-26 1995-01-25 Gebro Broschek Gmbh Verfahren zur intramolekularen oxidation von zwei -sh gruppen in einer peptidverbindung zu einer disulfidbrücke
EP0620230A1 (en) * 1989-04-15 1994-10-19 Nippon Chemiphar Co., Ltd. Peptides and antidementia agents containing the same
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
US20030166147A1 (en) * 2001-12-14 2003-09-04 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
JP2005512538A (ja) * 2001-12-14 2005-05-12 セントカー・インコーポレーテツド 無血清培地中でタンパク質を製造するのに有用なクローン性骨髄腫細胞系
US20040152170A1 (en) * 2001-12-14 2004-08-05 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
EP1555029A1 (en) 2004-01-19 2005-07-20 Ferring B.V. Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
US8030446B2 (en) * 2006-02-10 2011-10-04 Trustees Of Dartmouth College Mutant proline-and-arginine rich peptides and methods for using the same
CN101357937B (zh) * 2007-07-31 2012-11-07 上海苏豪逸明制药有限公司 固相多肽合成阿托西般的制备方法
CN102127146B (zh) * 2010-12-24 2013-04-24 深圳翰宇药业股份有限公司 一种制备醋酸阿托西班的方法
CN102584953B (zh) * 2012-02-09 2014-01-01 深圳翰宇药业股份有限公司 一种阿托西班的纯化方法
HUE058871T2 (hu) 2016-01-04 2022-09-28 Merck Serono Sa Hidroxipropil-tiazolidin-karboxamid származék L-valinátja, ennek sója és kristályformája
MA52548A (fr) 2016-07-21 2021-05-26 ObsEva SA Régimes posologiques d'antagonistes de l'ocytocine pour favoriser l'implantation d'embryons et prévenir les fausses couches
AU2020340670A1 (en) 2019-09-03 2022-04-07 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CN115380122A (zh) 2020-02-10 2022-11-22 奥布赛瓦股份公司 用于催产素受体拮抗剂疗法的生物标志物
JP2023550555A (ja) 2020-11-16 2023-12-01 ゾーマ（ユーエス） エルエルシー 早期分娩の治療または予防のための組成物及び方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051686A (fi) * 1963-04-05
NL129421C (fi) * 1963-08-30 1900-01-01
CH442342A (de) * 1964-07-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
ZA733419B (en) * 1972-07-04 1974-03-27 Hoffmann La Roche Nonapeptides and process for the preparation thereof
US4081533A (en) * 1976-09-01 1978-03-28 Regents Of The University Of California Method of reducing mammalian fertility and drugs therefor
US4163011A (en) * 1978-08-28 1979-07-31 Orts Richard J Peptide compounds and compositions
SE430885B (sv) * 1980-03-24 1983-12-19 Ferring Ab Oxytocin-derivat
US4367225A (en) * 1981-03-24 1983-01-04 The Medical College Of Ohio Novel antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin

Also Published As

Publication number Publication date
DK163186C (da) 1992-06-22
DE10075020I2 (de) 2003-01-09
FI834634A (fi) 1984-06-22
ES528211A0 (es) 1986-06-01
NO834691L (no) 1984-06-22
CA1216843A (en) 1987-01-20
DE3363830D1 (en) 1986-07-03
EP0112809A1 (en) 1984-07-04
FI78305C (fi) 1989-07-10
ES8607990A1 (es) 1986-06-01
DK586783D0 (da) 1983-12-20
NL300012I2 (nl) 2001-02-01
US4504469A (en) 1985-03-12
IL70498A0 (en) 1984-03-30
AU2257783A (en) 1984-06-28
DE10075020I1 (de) 2000-09-21
DK586783A (da) 1984-06-22
FI78305B (fi) 1989-03-31
ATE20072T1 (de) 1986-06-15
DK163186B (da) 1992-02-03
NO160144B (no) 1988-12-05
NL300012I1 (nl) 2000-10-02
IL70498A (en) 1987-09-16
AU564255B2 (en) 1987-08-06
NO160144C (no) 1989-03-15
EP0112809B1 (en) 1986-05-28

Similar Documents

Publication Publication Date Title
DE3363830D1 (en) Vasotocin derivatives
US4005063A (en) [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
EP0100218B1 (en) Gnrh antagonists
CA1262399A (en) Gnrh antagonists
US4565804A (en) GnRH Antagonists VI
GB1498048A (en) Decapeptide amides
Sievertsson et al. Hypothalamic hormones. 35. Two syntheses of the luteinizing hormone releasing hormone of the hypothalamus
ATE42308T1 (de) Pharmakologisch aktive peptide.
IE51068B1 (en) Lrf antagonists
IE58287B1 (en) Spiro-heteroazolones for treatment of diabetes complications
DK74780A (da) Psyko-farmakologiske peptider
KITAGAWA et al. Alternative Synthesis of Substance P
GB1155925A (en) Synthesis Of Octapeptides
ATE17585T1 (de) Peptide.
北川幸己 et al. Alternative synthesis of substance P.

Legal Events

Date Code Title Description
MA Patent expired

Owner name: FERRING AB